Division of Endocrine Surgery, Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Ann Surg Oncol. 2012 Jul;19(7):2288-94. doi: 10.1245/s10434-012-2296-4. Epub 2012 Mar 7.
Although recent studies have shown the feasibility and safety of robotic adrenalectomy, an advantage over the laparoscopic approach has not been demonstrated. Our hypothesis was that the use of the robot would facilitate minimally invasive resection of large adrenal tumors.
Adrenal tumors≥5 cm resected robotically were compared with those removed laparoscopically from a prospective institutional review board-approved adrenal database. Clinical and perioperative parameters were analyzed using t and chi-square tests. All data are expressed as mean±standard error of mean.
There were 24 patients with 25 tumors in the robotic group and 38 patients with 38 tumors in the laparoscopic group. Tumor size was similar in both groups (6.5±0.4 [robotic] vs 6.2±0.3 cm [laparoscopic], P=.661). Operative time was shorter for the robotic versus laparoscopic group (159.4±13.4 vs 187.2±8.3 min, respectively, P=.043), while estimated blood loss was similar (P=.147). The conversion to open rate was less in the robotic (4%) versus the laparoscopic (11%) group; P=.043. Hospital stay was shorter for the robotic group (1.4±0.2 vs 1.9±0.1 days, respectively, P=.009). The 30-day morbidity was 0 in robotic and 2.7% in laparoscopic group. Pathology was similar between groups.
Our study shows that the use of the robot could shorten operative time and decrease the rate of conversion to open for adrenal tumors larger than 5 cm. Based on our favorable experience, robotic adrenalectomy has become our preferred minimally invasive surgical approach for removing large adrenal tumors.
虽然最近的研究表明机器人肾上腺切除术具有可行性和安全性,但与腹腔镜方法相比,其优势尚未得到证明。我们的假设是,使用机器人将有助于微创切除大型肾上腺肿瘤。
从一个机构审查委员会批准的前瞻性肾上腺数据库中,比较机器人辅助切除的≥5cm 的肾上腺肿瘤与腹腔镜切除的肿瘤。使用 t 检验和卡方检验分析临床和围手术期参数。所有数据均表示为均数±标准误。
机器人组有 24 例 25 个肿瘤,腹腔镜组有 38 例 38 个肿瘤。两组肿瘤大小相似(机器人组 6.5±0.4cm,腹腔镜组 6.2±0.3cm,P=.661)。机器人组的手术时间短于腹腔镜组(分别为 159.4±13.4min 和 187.2±8.3min,P=.043),而估计出血量相似(P=.147)。机器人组的中转开放率低于腹腔镜组(4%比 11%,P=.043)。机器人组的住院时间短于腹腔镜组(分别为 1.4±0.2 天和 1.9±0.1 天,P=.009)。机器人组的 30 天发病率为 0%,腹腔镜组为 2.7%。两组的病理结果相似。
我们的研究表明,使用机器人可以缩短手术时间,并降低大于 5cm 的肾上腺肿瘤转为开放手术的比例。基于我们的良好经验,机器人肾上腺切除术已成为我们切除大型肾上腺肿瘤的首选微创手术方法。